Equator Therapeutics

About:

Restoring natural heat production to treat metabolic disorders

Website: https://equatortherapeutics.com/

Top Investors: Y Combinator, Sand Hill Angels, Alameda Research

Description:

Equator Therapeutics develops a drug that burns calories and improves metabolism. It offers a drug that can solve obesity and type 2 diabetes problem because it addresses the root cause of metabolic disorders. Its drug will target mitochondria, the powerhouse of the cell. It will activate the protein that mitochondria naturally use to produce heat. The company's approach has been proven to reverse obesity and type 2 diabetes in animals. It has developed a high-throughput drug discovery platform to identify compounds that selectively activate its target protein, without side effects.

Total Funding Amount:

$650000

Estimated Revenue Range:

Less than $1M

Headquarters Location:

San Francisco, California, United States

Founded Date:

2020-01-01

Contact Email:

founders(AT)equatortherapeutics.com

Founders:

Jonah Sinick, Liliya Gabelev, Michael Grabe, Yuriy Kirichok

Number of Employees:

1-10

Last Funding Date:

2022-01-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai